BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33741806)

  • 1. Practical management strategies for benign hypermobility syndromes.
    Minhas D
    Curr Opin Rheumatol; 2021 May; 33(3):249-254. PubMed ID: 33741806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a self-management intervention to manage hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (hEDS): an analysis informed by behaviour change theory.
    Bennett SE; Walsh N; Moss T; Palmer S
    Disabil Rehabil; 2022 Sep; 44(18):5231-5240. PubMed ID: 34101520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome.
    Engelbert RH; Juul-Kristensen B; Pacey V; de Wandele I; Smeenk S; Woinarosky N; Sabo S; Scheper MC; Russek L; Simmonds JV
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):158-167. PubMed ID: 28306230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and mechanical therapies for lower limb symptoms in children with Hypermobility Spectrum Disorder and Hypermobile Ehlers-Danlos Syndrome: a systematic review.
    Peterson B; Coda A; Pacey V; Hawke F
    J Foot Ankle Res; 2018; 11():59. PubMed ID: 30455744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical therapy interventions in generalized hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: a scoping review.
    Garreth Brittain M; Flanagan S; Foreman L; Teran-Wodzinski P
    Disabil Rehabil; 2024 May; 46(10):1936-1953. PubMed ID: 37231592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognizing and Effectively Managing Hypermobility-Related Conditions.
    Russek LN; Stott P; Simmonds J
    Phys Ther; 2019 Sep; 99(9):1189-1200. PubMed ID: 31158283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative measures of tissue mechanics to detect hypermobile Ehlers-Danlos syndrome and hypermobility syndrome disorders: a systematic review.
    Palmer S; Denner E; Riglar M; Scannell H; Webb S; Young G
    Clin Rheumatol; 2020 Mar; 39(3):715-725. PubMed ID: 31955324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised controlled trial of heavy shoulder strengthening exercise in patients with hypermobility spectrum disorder or hypermobile Ehlers-Danlos syndrome and long-lasting shoulder complaints: study protocol for the Shoulder-MOBILEX study.
    Liaghat B; Skou ST; Søndergaard J; Boyle E; Søgaard K; Juul-Kristensen B
    Trials; 2020 Dec; 21(1):992. PubMed ID: 33261635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Ehlers Danlos syndrome : a rare disease although commonly suspected].
    Docampo E; Lehane F; Ribbens C
    Rev Med Liege; 2023 Nov; 78(11):626-633. PubMed ID: 37955292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary approach to joint hypermobility and related disorders.
    Castori M; Hakim A
    Curr Opin Pediatr; 2017 Dec; 29(6):640-649. PubMed ID: 28906340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.
    Ritelli M; Chiarelli N; Cinquina V; Vezzoli M; Venturini M; Colombi M
    Am J Med Genet A; 2024 Feb; 194(2):174-194. PubMed ID: 37774134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
    Tinkle B; Castori M; Berglund B; Cohen H; Grahame R; Kazkaz H; Levy H
    Am J Med Genet C Semin Med Genet; 2017 Mar; 175(1):48-69. PubMed ID: 28145611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.
    Menton SM; Fairweather D; Bruno KA; Thompson CC; Candelo E; Darakjian AA; Gehin JM; Jain A; Kotha A; Whelan ER; Li Z; Knight DRT; Rutt AL
    Laryngoscope; 2024 Feb; 134(2):773-778. PubMed ID: 37597175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cell activation and nutritional disorders in patients with hypermobility.
    Penny HA; Aziz I; Lam C
    Curr Opin Gastroenterol; 2024 May; 40(3):225-232. PubMed ID: 38393310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic Joint Hypermobility: The Hypermobile Type of Ehlers-Danlos Syndrome and the Hypermobility Spectrum Disorders.
    Tinkle BT; Levy HP
    Med Clin North Am; 2019 Nov; 103(6):1021-1033. PubMed ID: 31582002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An acquired or heritable connective tissue disorder? A review of hypermobile Ehlers Danlos Syndrome.
    Martin A
    Eur J Med Genet; 2019 Jul; 62(7):103672. PubMed ID: 31102747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subacromial space outlet in female patients with multidirectional instability based on hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder measured by ultrasound.
    Kjær BH; de Wandele I; Spanhove V; Juul-Kristensen B; Cools AM
    J Shoulder Elbow Surg; 2020 Mar; 29(3):600-608. PubMed ID: 31629650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding hypermobile Ehlers-Danlos syndrome and Hypermobility Spectrum Disorders in the context of childbearing: An international qualitative study.
    Pezaro DS; Pearce DG; Reinhold DE
    Midwifery; 2020 Sep; 88():102749. PubMed ID: 32535291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of five isometric exercises on glenohumeral translations in healthy subjects and patients with the hypermobility type of the ehlers-danlos syndrome (heds) or hypermobility spectrum disorder (hsd) with multidirectional shoulder instability: an observational study.
    Spanhove V; De Wandele I; Kjær BH; Malfait F; Vanderstukken F; Cools A
    Physiotherapy; 2020 Jun; 107():11-18. PubMed ID: 32026810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.